Human African Trypanosomiasis
📧 Sign up to get email alerts when something new happens for Human African Trypanosomiasis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-27New single-dose oral treatment for human African trypanosomiasis (sleeping sickness)
EMA approved acoziborole as a single-dose oral treatment for both stages of gambiense human African trypanosomiasis, simplifying management …
-
FDA approval · 2024-09-20FDA Approved: FEXINIDAZOLE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for fexinidazole submitted by Sanofi-Aventis U.S. LLC. This action updates the regulatory record for…
-
FDA approval · 2021-12-15FDA Approved: FEXINIDAZOLE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for fexinidazole from Sanofi-Aventis U.S. LLC, updating the product label (and indications) for the …
-
FDA approval · 2021-07-16FDA Approved: FEXINIDAZOLE — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved fexinidazole (Sanofi-Aventis U.S. LLC) for the treatment of human African trypanosomiasis (sleeping sickness) in the United Sta…